Spdr S&p 500 Etf Tr Tr Unit Put Option
(SPY)
|
54.2 |
$339M |
|
750k |
451.64 |
Springworks Therapeutics
(SWTX)
|
3.7 |
$23M |
|
407k |
56.44 |
Inari Medical Ord
(NARI)
|
3.2 |
$20M |
|
220k |
90.64 |
Morphic Hldg
(MORF)
|
3.0 |
$19M |
|
466k |
40.15 |
Kura Oncology
(KURA)
|
2.4 |
$15M |
|
924k |
16.08 |
Ascendis Pharma A/s Sponsored Adr
(ASND)
|
2.3 |
$14M |
|
120k |
117.36 |
Chinook Therapeutics
|
2.2 |
$14M |
|
845k |
16.36 |
Protagonist Therapeutics
(PTGX)
|
2.0 |
$12M |
|
516k |
23.68 |
Establishment Labs Holdings Ord
(ESTA)
|
1.9 |
$12M |
|
175k |
67.39 |
Travere Therapeutics Note 2.500% 9/1 (Principal)
|
1.8 |
$12M |
|
11M |
1.04 |
Astrazeneca Sponsored Adr
(AZN)
|
1.7 |
$11M |
|
160k |
66.34 |
Zentalis Pharmaceuticals
(ZNTL)
|
1.5 |
$9.6M |
|
208k |
46.14 |
Lantheus Holdings Inc Common Stock Usd 0.01
(LNTH)
|
1.4 |
$8.6M |
|
155k |
55.31 |
Nanostring Technologies Note 2.625% 3/0 (Principal)
|
1.2 |
$7.8M |
|
7.0M |
1.11 |
Madrigal Pharmaceuticals
(MDGL)
|
1.2 |
$7.4M |
|
75k |
98.12 |
Arya Sciences Acquisitn Corp Class A Ord Shs
|
1.1 |
$6.8M |
|
703k |
9.72 |
Repare Therapeutics Ord
(RPTX)
|
1.1 |
$6.7M |
|
469k |
14.24 |
Pmv Pharmaceuticals Call Option
(PMVP)
|
1.1 |
$6.6M |
|
317k |
20.82 |
Nanostring Technologies
(NSTGQ)
|
1.0 |
$6.0M |
|
172k |
34.75 |
Vincerx Pharma Com New
(VINC)
|
0.9 |
$5.5M |
|
1.4M |
4.00 |
Rocket Pharmaceuticals
(RCKT)
|
0.8 |
$4.8M |
|
300k |
15.86 |
Bridgebio Pharma Note 2.250% 2/0 (Principal)
|
0.7 |
$4.7M |
|
10M |
0.47 |
Bridgebio Pharma Note 2.500% 3/1 (Principal)
|
0.7 |
$4.4M |
|
7.5M |
0.58 |
Celldex Therapeutics Com New
(CLDX)
|
0.7 |
$4.3M |
|
125k |
34.06 |
Bellus Health Com New
|
0.7 |
$4.1M |
|
600k |
6.88 |
Cymabay Therapeutics
|
0.6 |
$4.0M |
|
1.3M |
3.11 |
Crispr Therapeutics Namen Akt Call Option
(CRSP)
|
0.6 |
$3.5M |
|
55k |
62.76 |
Horizon Therapeutics Pub L SHS
|
0.5 |
$3.2M |
|
30k |
105.20 |
Health Sciences Acq Corp 2 Ord Shs
|
0.5 |
$3.0M |
|
300k |
9.91 |
Medicus Sciences Acquisition Cl A Shs
|
0.5 |
$2.9M |
|
300k |
9.78 |
Travere Therapeutics
(TVTX)
|
0.4 |
$2.6M |
|
100k |
25.77 |
Cerevel Therapeutics Hldng I
(CERE)
|
0.4 |
$2.5M |
|
70k |
35.01 |
Xenon Pharmaceuticals
(XENE)
|
0.4 |
$2.4M |
|
80k |
30.57 |
Nautilus Biotechnology
(NAUT)
|
0.4 |
$2.4M |
|
559k |
4.34 |
Global Blood Therapeutics In
|
0.4 |
$2.4M |
|
70k |
34.64 |
Relay Therapeutics Call Option
(RLAY)
|
0.4 |
$2.2M |
|
75k |
29.93 |
Aurinia Pharmaceuticals Call Option
(AUPH)
|
0.3 |
$2.2M |
|
175k |
12.38 |
Aclaris Therapeutics
(ACRS)
|
0.3 |
$1.7M |
|
100k |
17.24 |
Beam Therapeutics Call Option
(BEAM)
|
0.3 |
$1.7M |
|
30k |
57.30 |
Context Therapeutics
(CNTX)
|
0.3 |
$1.7M |
|
778k |
2.17 |
Cyclacel Pharmaceuticals
|
0.2 |
$1.2M |
|
400k |
3.05 |
Lianbio Sponsored Ads
(LIANY)
|
0.2 |
$1.2M |
|
325k |
3.71 |
Science 37 Holdings
|
0.2 |
$1.2M |
|
221k |
5.35 |
Karuna Therapeutics Ord
|
0.2 |
$951k |
|
7.5k |
126.80 |
Miragen Therapeutics
(VRDN)
|
0.1 |
$925k |
|
50k |
18.50 |
Athersys Put Option
|
0.1 |
$858k |
|
1.4M |
0.61 |
Renovacor
|
0.1 |
$846k |
|
200k |
4.24 |
Curis Com New
|
0.1 |
$833k |
|
350k |
2.38 |
Celularity Com Cl A Put Option
|
0.1 |
$697k |
|
80k |
8.71 |
Centessa Pharmaceuticals Sponsored Ads
(CNTA)
|
0.1 |
$586k |
|
65k |
8.98 |
Calithera Biosciences
|
0.1 |
$404k |
|
1.0M |
0.40 |
Immatics *w Exp 07/01/202
(IMTXW)
|
0.1 |
$328k |
|
187k |
1.75 |
Hyperfine Com Cl A
(HYPR)
|
0.0 |
$270k |
|
76k |
3.55 |
Blueprint Medicines
(BPMC)
|
0.0 |
$127k |
|
2.0k |
63.88 |
Renovacor *w Exp 99/99/999
|
0.0 |
$26k |
|
75k |
0.35 |
Medicus Sciences Acquisition *w Exp 02/12/202
|
0.0 |
$14k |
|
33k |
0.42 |